DK1135401T3 - Glycerylnucleotider, fremgangsmåder til deres fremstilling og deres anvendelse - Google Patents
Glycerylnucleotider, fremgangsmåder til deres fremstilling og deres anvendelseInfo
- Publication number
- DK1135401T3 DK1135401T3 DK99958161T DK99958161T DK1135401T3 DK 1135401 T3 DK1135401 T3 DK 1135401T3 DK 99958161 T DK99958161 T DK 99958161T DK 99958161 T DK99958161 T DK 99958161T DK 1135401 T3 DK1135401 T3 DK 1135401T3
- Authority
- DK
- Denmark
- Prior art keywords
- radicals
- nucleoside
- compounds
- processes
- group
- Prior art date
Links
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 title abstract 2
- 150000003254 radicals Chemical class 0.000 abstract 5
- 125000003835 nucleoside group Chemical group 0.000 abstract 4
- -1 polyoxyalkenyl Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 101100406515 Drosophila melanogaster orb2 gene Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 101100258025 Schizosaccharomyces pombe (strain 972 / ATCC 24843) shk1 gene Proteins 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000005035 acylthio group Chemical group 0.000 abstract 1
- 125000003302 alkenyloxy group Chemical group 0.000 abstract 1
- 125000005108 alkenylthio group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000005840 aryl radicals Chemical class 0.000 abstract 1
- 125000005110 aryl thio group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H19/207—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19855963A DE19855963A1 (de) | 1998-12-04 | 1998-12-04 | Amphiphile Glycerylnucleotide, Verfahren zu ihrer Herstellung und ihre Verwendung |
| PCT/EP1999/009461 WO2000034298A1 (de) | 1998-12-04 | 1999-12-03 | Glycerylnucleotide, verfahren zu ihrer herstellung und ihre verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1135401T3 true DK1135401T3 (da) | 2003-10-06 |
Family
ID=7889957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99958161T DK1135401T3 (da) | 1998-12-04 | 1999-12-03 | Glycerylnucleotider, fremgangsmåder til deres fremstilling og deres anvendelse |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6787525B1 (https=) |
| EP (1) | EP1135401B1 (https=) |
| JP (1) | JP4879398B2 (https=) |
| AT (1) | ATE243220T1 (https=) |
| AU (1) | AU1558800A (https=) |
| CA (1) | CA2352229C (https=) |
| DE (2) | DE19855963A1 (https=) |
| DK (1) | DK1135401T3 (https=) |
| ES (1) | ES2201805T3 (https=) |
| WO (1) | WO2000034298A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10228059B4 (de) * | 2002-06-19 | 2005-12-29 | Eberhard-Karls-Universität Tübingen | Verwendung von amphiphilen Nucleosid-Phosphonoameisensäure-Derivaten zur Behandlung von viralen Infektionskrankheiten |
| US7593913B2 (en) * | 2006-01-11 | 2009-09-22 | Siemens Medical Solutions Usa, Inc. | Systems and method for integrative medical decision support |
| EP2619215B1 (en) | 2010-09-22 | 2018-09-05 | Alios Biopharma, Inc. | Azido nucleosides and nucleotide analogs |
| SG10201913554YA (en) | 2011-12-22 | 2020-03-30 | Alios Biopharma Inc | Substituted nucleosides, nucleotides and analogs thereof |
| US9441007B2 (en) | 2012-03-21 | 2016-09-13 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| USRE48171E1 (en) | 2012-03-21 | 2020-08-25 | Janssen Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
| MX2014014323A (es) | 2012-05-25 | 2015-02-12 | Janssen R & D Ireland | Nucleosidos de espirooxetano de uracilo. |
| BR112015014457A2 (pt) | 2012-12-21 | 2017-11-21 | Alios Biopharma Inc | composto ou sal farmaceuticamente aceitável do mesmo e composição farmacêutica e respectivos usos e processos para melhorar ou tratar infecção de hcv, para inibir a atividade da ns5b polimerase do vírus da hepatite c e a replicação de vírus da hepatite c |
| WO2015054465A1 (en) | 2013-10-11 | 2015-04-16 | Alios Biopharma, Inc. | Substituted nucleosides, nucleotides and analogs thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03236396A (ja) * | 1990-02-10 | 1991-10-22 | Tosoh Corp | 修飾オリゴデオキシヌクレオチド及びそれを含むｄｎａ |
| JPH0421694A (ja) * | 1990-05-16 | 1992-01-24 | Asahi Chem Ind Co Ltd | 新規なヌクレオシド―リン脂質複合体 |
| WO1991019726A1 (en) * | 1990-06-15 | 1991-12-26 | Wake Forest University | Ether lipid-nucleoside covalent conjugates |
| CA2129986C (en) | 1992-02-13 | 2003-12-09 | Albert Reto Schwendener | Amphiphile nucleosidphosphatanaloga |
| DE4418690A1 (de) * | 1994-05-28 | 1996-01-11 | Boehringer Mannheim Gmbh | Neue Lipidester von Nucleosid-Monophosphaten und deren Verwendung als immunsuppressive Arzneimittel |
| JP4259611B2 (ja) * | 1994-08-29 | 2009-04-30 | ウェイク フォレスト ユニバーシティ | ウィルス感染を治療するための脂質アナログ |
| WO1998028978A1 (en) * | 1996-05-08 | 1998-07-09 | Weider Nutrition Group, Inc. | Structured glycerols and structured phosphatides |
| US6686462B2 (en) * | 1997-02-28 | 2004-02-03 | The Regents Of The University Of California | Antiviral compounds and methods of administration |
-
1998
- 1998-12-04 DE DE19855963A patent/DE19855963A1/de not_active Withdrawn
-
1999
- 1999-12-03 AU AU15588/00A patent/AU1558800A/en not_active Abandoned
- 1999-12-03 DE DE59906041T patent/DE59906041D1/de not_active Expired - Lifetime
- 1999-12-03 EP EP99958161A patent/EP1135401B1/de not_active Expired - Lifetime
- 1999-12-03 DK DK99958161T patent/DK1135401T3/da active
- 1999-12-03 WO PCT/EP1999/009461 patent/WO2000034298A1/de not_active Ceased
- 1999-12-03 ES ES99958161T patent/ES2201805T3/es not_active Expired - Lifetime
- 1999-12-03 JP JP2000586741A patent/JP4879398B2/ja not_active Expired - Fee Related
- 1999-12-03 AT AT99958161T patent/ATE243220T1/de not_active IP Right Cessation
- 1999-12-03 US US09/856,165 patent/US6787525B1/en not_active Expired - Fee Related
- 1999-12-03 CA CA002352229A patent/CA2352229C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6787525B1 (en) | 2004-09-07 |
| CA2352229A1 (en) | 2000-06-15 |
| EP1135401A1 (de) | 2001-09-26 |
| ES2201805T3 (es) | 2004-03-16 |
| JP2002531573A (ja) | 2002-09-24 |
| AU1558800A (en) | 2000-06-26 |
| DE59906041D1 (de) | 2003-07-24 |
| DE19855963A1 (de) | 2000-06-08 |
| CA2352229C (en) | 2009-06-09 |
| JP4879398B2 (ja) | 2012-02-22 |
| ATE243220T1 (de) | 2003-07-15 |
| EP1135401B1 (de) | 2003-06-18 |
| WO2000034298A1 (de) | 2000-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0481214T3 (da) | Prolægemidler af phosphonater | |
| DK1914237T3 (da) | Antivirale fosfonatesterforbindelser | |
| CY1121639T1 (el) | Συνθεσεις που περιλαμβανουν προφαρμακα νουκλεοτιδιων και ολιγονουκλεοτιδιων | |
| UY28084A1 (es) | Derivados antivirales de nucleosidos | |
| BR0211900A (pt) | Método para inibição do desenvolvimento de vìrus e/ou virucida, análogos de nucleotìdeo de pirazina e de nucleosìdeo de pirazina, precursor do inibidor da polimerase de rna, inibidor da polimerase de rna, método para tratar pacientes infectados por vìrus, e, usos de um análogo de nucleotìdeo de pirazina ou um sal deste e de um análogo de nucleosìdeo de pirazina ou um sal deste | |
| AR021844A1 (es) | Derivados de propanolamina aril-sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y su utilizacion | |
| KR920002625A (ko) | 말단에 3'-3' 또는 5'-5' 뉴클레오타이드간 결합을 갖는 올리고뉴클레오타이드 유사체 | |
| BR9808010A (pt) | Compostos de 2-alquil-19-nor-vitamina d | |
| NO940825L (no) | 2-Debenzoyl-2-acyltaxolderivater og fremgangsmåter ved fremstilling derav | |
| EP1201678A4 (en) | BICYCLONUCLEOSID Analogs | |
| NO940804D0 (no) | Imidazolidylmakrolider | |
| DK1135401T3 (da) | Glycerylnucleotider, fremgangsmåder til deres fremstilling og deres anvendelse | |
| BR9708114A (pt) | Análogos xantona para o tratamento de doenças infecciosas. | |
| DK0517986T3 (da) | Transformerede erythrocytter, fremgangsmåde til fremstilling af samme og deres anvendelse i farmaceutiske præparater | |
| ATE178903T1 (de) | Sulfamat-derivate von 1,3,5(10)-estratrien- derivaten, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
| PT77991A (en) | Process for the preparation of benzoylurea compounds and pesticidal and pharmaceutical compositions comprising same and for their utilization in the control of insects and/or acarids and for combating tumors in living beings respectively | |
| IL172015A (en) | Phosphonate grouping shaft compounds, method of preparation and use thereof for the preparation of drugs for the treatment of viral infection | |
| BRPI0417988A (pt) | análogos de fosfonato antivirais | |
| ATE346036T1 (de) | Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen | |
| KR910016751A (ko) | 치환된 푸린, 이의 제조방법 및 항비루스제로서의 이의 용도 | |
| ES2150107T3 (es) | Inmunogenos no toxicos que proceden de una proteina de regulacion retroviral, anticuerpos dirigidos contra estos inmunogenos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
| RU2005128830A (ru) | Обладающие противоопухолевым действием 2-замещенные d-гомоэстра-1, 3, 5( 10 )-триен-3-илсульфаматы | |
| AU668506B2 (en) | Targeted drug delivery via mixed phosphate derivatives | |
| EE200200302A (et) | Küllastumata 14,15-tsüklopropanoandrostaanid, nende valmistamise meetod ja neid ühendeid sisaldavadfarmatseutilised kompositsioonid | |
| BRPI0409766A (pt) | análogos de fosfonato antiviral |